Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06520397
What this trial is testing

Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease

Who this might be right for
Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University 214
Post-approval studies (Phase 4)Study completedNCT01034397
What this trial is testing

Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 54
Not applicableNot Yet RecruitingNCT07644754
What this trial is testing

Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases

Who this might be right for
Prostate CancerProstate Cancer Metastatic DiseaseProstate Cancer Metastatic to Bone
University Hospital Tuebingen 27
Testing effectiveness (Phase 2)Study completedNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Not applicableStudy completedNCT01362062
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 110
Large-scale testing (Phase 3)Study completedNCT02746380
What this trial is testing

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Rheumatoid
LG Life Sciences 383
Large-scale testing (Phase 3)Study completedNCT01436162
What this trial is testing

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Shire 1,105
Testing effectiveness (Phase 2)Ended earlyNCT02882087
What this trial is testing

The Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Who this might be right for
Moderate and Severe Rheumatoid Arthritis
RemeGen Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT03616834
What this trial is testing

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Who this might be right for
Solid Tumors
Effector Therapeutics 39
Testing effectiveness (Phase 2)Study completedNCT01430507
What this trial is testing

A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Glenmark Pharmaceuticals Ltd. India 406
Large-scale testing (Phase 3)Looking for participantsNCT05751967
What this trial is testing

Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases 150
Large-scale testing (Phase 3)UnknownNCT02357069
What this trial is testing

A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Rheumatoid
LG Life Sciences 372
Post-approval studies (Phase 4)Ended earlyNCT00796705
What this trial is testing

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID) 13
Large-scale testing (Phase 3)Ended earlyNCT01198002
What this trial is testing

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 1,041
Large-scale testing (Phase 3)Study completedNCT02706951
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Who this might be right for
Rheumatoid Arthritis
AbbVie 648
Large-scale testing (Phase 3)Active Not RecruitingNCT06241118
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Who this might be right for
Dermatitis Atopic
Sanofi 464
Testing effectiveness (Phase 2)Ended earlyNCT04680637
What this trial is testing

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Active Systemic Lupus Erythematosus
Amgen 168
Testing effectiveness (Phase 2)Study completedNCT05133297
What this trial is testing

The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hangzhou Highlightll Pharmaceutical Co., Ltd 101
Testing effectiveness (Phase 2)Study completedNCT03682705
What this trial is testing

Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 242
Large-scale testing (Phase 3)Study completedNCT02400346
What this trial is testing

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Who this might be right for
Major Depression Disorder
H. Lundbeck A/S 132
Next Page